VA
Valmark Advisers’s MaxCyte MXCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-123,203
| Closed | -$336K | – | 645 |
|
|
2025
Q1 | $336K | Buy |
123,203
+7,549
| +7% | +$20.6K | 0.01% | 491 |
|
|
2024
Q4 | $481K | Buy |
115,654
+2,478
| +2% | +$10.3K | 0.01% | 424 |
|
|
2024
Q3 | $440K | Sell |
113,176
-342
| -0.3% | -$1.33K | 0.01% | 439 |
|
|
2024
Q2 | $445K | Sell |
113,518
-2,562
| -2% | -$10K | 0.01% | 413 |
|
|
2024
Q1 | $486K | Buy |
116,080
+32,153
| +38% | +$135K | 0.01% | 385 |
|
|
2023
Q4 | $394K | Buy |
+83,927
| New | +$394K | 0.01% | 388 |
|
|
2023
Q3 | – | Sell |
-163,056
| Closed | -$748K | – | 480 |
|
|
2023
Q2 | $748K | Buy |
163,056
+91,177
| +127% | +$419K | 0.02% | 266 |
|
|
2023
Q1 | $356K | Buy |
71,879
+30,202
| +72% | +$150K | 0.01% | 364 |
|
|
2022
Q4 | $228K | Buy |
41,677
+7,118
| +21% | +$38.9K | 0.01% | 407 |
|
|
2022
Q3 | $225K | Buy |
+34,559
| New | +$225K | ﹤0.01% | 383 |
|